Pflug Koory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Pflug Koory's REGN Position: Q2 2026 in Review
Pflug Koory held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 994 shares worth $620K. The position accounts for 0.25% of the portfolio, ranked #87.
Pflug Koory first reported a position in REGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.1M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Pflug Koory held 994 shares of Regeneron Pharmaceuticals worth $620K as of Q2 2026.
- Pflug Koory left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.25% of Pflug Koory's portfolio in Q2 2026, its #87 holding.
- Pflug Koory first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
- Pflug Koory's Regeneron Pharmaceuticals position peaked at $1.1M in Q3 2024.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.